CB
Cibus, Inc. (CBUS)
NASDAQ·Healthcare·Biotechnology
$1.96
+3.44%
Mkt Cap $81.42M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$11.50
Range $10.50 – $12.50
Implied Upside
+486.7%
Consensus $11.50 vs current $1.96
NASDAQ·Healthcare·Biotechnology
$1.96
+3.44%
Mkt Cap $81.42M
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$11.50
Range $10.50 – $12.50
+486.7%
Consensus $11.50 vs current $1.96